End-Stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing

Loading...
Thumbnail Image
Penn collection
Business Economics and Public Policy Papers
Degree type
Discipline
Subject
Finance and Financial Management
Health Economics
Funder
Grant number
License
Copyright date
Distributor
Related resources
Author
Doraszelski, Avi
Pauly, Mark V
Eichleay, Margaret A
Held, Philip J
Contributor
Abstract

End-stage renal disease (ESRD), or kidney failure, is a debilitating, costly, and increasingly common medical condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with alternative models of incentives and benefits, collected under the International Study of Health Care Organization and Financing, a substudy within the Dialysis Outcomes and Practice Patterns Study. Variation in spending per ESRD patient is relatively small and is correlated with overall per capita health care spending. Between-country variations in spending are reduced using an input price parity index constructed for this study. Remaining differences in costs and outcomes do not seem strongly linked to differences in incentives embedded in national programs.

Advisor
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Publication date
2007-09-01
Journal title
International Journal of Health Care Finance and Economics
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Comments
Recommended citation
Collection